Invisible Symptoms: Cognition and MS
Episode 57, Feb 11, 2022, 11:00 AM
Welcome to the NeurologyLive® Mind Moments™ podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with Dhanashri P. Miskin, MD, clinical assistant professor of neurology, Thomas Jefferson University Hospitals. She offered her insight into the role that cognitive impairment plays as a symptom of multiple sclerosis (MS), the current approach to treatment and management for patients, and what challenges remain for the field to address.
Episode Breakdown:
In this episode, we spoke with Dhanashri P. Miskin, MD, clinical assistant professor of neurology, Thomas Jefferson University Hospitals. She offered her insight into the role that cognitive impairment plays as a symptom of multiple sclerosis (MS), the current approach to treatment and management for patients, and what challenges remain for the field to address.
Episode Breakdown:
- 1:25 – Background on cognitive symptoms of MS
- 4:25 – Prevalence of cognitive issues for patients
- 6:05 – Current understanding of the driving factors of cognitive issues
- 8:15 – Management practices and approaches to prevention
- 13:20 – Tips on talking to patients about preventive approaches
- 16:30 – Neurology News Minute
- 19:10 – Challenges in helping patients adjust behavioral habits
- 23:20 – Advances in tracking cognitive changes in MS
- 28:00 – Potential role of EBV infection on these processes
- 30:35 – Most glaring need in addressing cognitive issues in MS
- 33:55 – COVID's impact on MS
Want to learn more about EBV and MS? Click here to register for free for an in-depth NeurologyLive®panel discussion including Scott Newsome, DO (moderator); Alberto Ascherio, DPh, MD; Anne Cross, MD; Avindra Nath, MD; and Michael Racke, MD.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
- 1-Week Epworth Sleepiness Scale for Children and Adolescents Validated for Pediatric Narcolepsy
- Baclofen Oral Suspension Approved for Treatment of Spasticity in Multiple Sclerosis
- Phase 2 Study of CY6463 in Alzheimer Disease With Vascular Pathology Initiated
Thanks for listening to the NeurologyLive® Mind Moments™ podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.